| Login |
| Description: | The University of Crete Medical School Graduate Program in Molecular Basis of Human Disease Seminar “Secukinumab a novel targeted IL-17A inhibitor, bench to bedside road map” Shephard Mpofu MD FRCP Global Program, Medical Director Integrated Hospital Care, Novartis Pharma AG Wednesday, December 11, 2013 10.00-12.00N Room 7A-0.1, Post-graduate Building, Medical School Host: P. Sidiropoulos (Tel.4873) Supported by the European Commission - funded program 'Translational Potential’ (TransPOT). |
| Status: | Waiting for approval |
| Date: | Wednesday, December 11, 2013 |
| Time: | 10:00-12:00 EET |
| Duration: | 2 hours |
| Priority: | 5-Medium |
| Access: | Public |
| Created by: | Lila Kalogeraki |
| Updated: | Tuesday, December 3, 2013 15:32 GMT |